Retraction

Serum calprotectin correlates with risk and disease severity in psoriasis patients and the decrease of calprotectin predicts better response to tumor necrosis factor inhibitors

Paper Information

Record ID:
30713
Publication Date:
July 01, 2018
Retraction Date:
May 01, 2021 (4.6 years years ago)
Article Type:
Publisher:
Verduci Editore
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Citations (6)

6
Total Citations
4
Post-Retraction
(66.7%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
872 Days since retraction (latest)
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
Pablo Coto‐Segura, Cristina Segú-Vergés, Antonio Martorell et al. (13 authors)
Frontiers in Immunology Open Access
Published: Sep 2023
4 citations
872 days after retraction
Heterogeneous effects of S100 proteins during cell interactions between immune cells and stromal cells from synovium or skin
Mélissa Noack, Pierre Miossec
Clinical & Experimental Immunology Open Access
Published: Mar 2023
670 days after retraction
Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease
Liliana F. Mellor, Nuria Gago‐López, Latifa Bakiri et al. (16 authors)
Annals of the Rheumatic Diseases Open Access
Published: Jul 2022
35 citations
429 days after retraction
Calprotectin: from biomarker to biological function
A Jukic, Latifa Bakiri, Erwin F. Wagner et al. (5 authors)
Gut Open Access
Published: Jun 2021
342 citations
48 days after retraction
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
Matthias Jarlborg, Delphine S. Courvoisier, Céline Lamacchia et al. (9 authors)
Arthritis Research & Therapy Open Access
Published: May 2020
98 citations
360 days before retraction
A Controlled Study of the Feasibility and Efficacy of a Cloud-Based Interactive Management Program Between Patients with Psoriasis and Physicians
Beibei Zhu, Yanyan Wang, Xuan Zhou et al. (9 authors)
Medical Science Monitor Open Access
Published: Feb 2019
11 citations
817 days before retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 4.6 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Effect of propofol on myocardial ischemia-reperfusion injur…
European Review for Medical and Pharmacological Sciences • 19 citations
MiR-299-3p inhibits proliferation and invasion of cervical …
European Review for Medical and Pharmacological Sciences • 19 citations
Aldose reductase inhibitor Epalrestat alleviates high gluco…
European Review for Medical and Pharmacological Sciences • 18 citations
MiR-15a-3p suppresses the growth and metastasis of ovarian …
European Review for Medical and Pharmacological Sciences • 18 citations
The inhibitory effect of miR-375 targeting sp1 in colorecta…
European Review for Medical and Pharmacological Sciences • 18 citations